Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole vs Famotidine for Recurrent UGI Bleeding Prevention in Aspirin Users
NCT01408186Phase 3Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2011
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of rabeprazole, famotidine in peptic ulcer disease (PUD), sponsored by The Chinese University of Hong Kong. Started Jan 2011; status: completed.
02
Drugs
rabeprazolefamotidine
03
Conditions
peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT01408186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01408186.